53
Views
4
CrossRef citations to date
0
Altmetric
Review

Role of tyrosine kinase inhibitors in the management of high-grade gliomas

, &
Pages 1739-1748 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mustafa Khasraw, Malaka Ameratunga & Christian Grommes. (2014) Bevacizumab for the treatment of high-grade glioma: an update after Phase III trials. Expert Opinion on Biological Therapy 14:5, pages 729-740.
Read now
Mustafa Khasraw, Marcelle Simeonovic & Christian Grommes. (2012) Bevacizumab for the treatment of high-grade glioma. Expert Opinion on Biological Therapy 12:8, pages 1101-1111.
Read now

Articles from other publishers (2)

Harpinder K. Brar, Jiney Jose, Zimei Wu & Manisha Sharma. (2022) Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery. Pharmaceutics 15:1, pages 59.
Crossref
Michael S. Roberts, David C. Turner, Thandranese S. Owens, Abhijit Ramachandran, Cynthia Wetmore, Stacy L. Throm & Clinton F. Stewart. (2013) Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography–electrospray ionization-tandem mass spectrometry (LC–ESI-MS/MS). Journal of Chromatography B 929, pages 1-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.